|
创伤性颅脑损伤神经炎症预后标志物研究进展
|
Abstract:
创伤性颅脑损伤在全世界范围内,都是导致患者死亡或致残的主要原因之一。脑外伤导致的神经炎症是大脑或脊髓细胞损伤的反应。神经炎症是一种复杂的现象,涉及大脑内神经免疫细胞和胶质细胞(例如星形胶质细胞和小胶质细胞),它们通过产生和释放细胞因子和炎症介质来被激活并对损伤做出反应。这些细胞因子与脑损伤部位的白细胞一起,促进了对损伤的协调反应。本文就创伤性颅脑损伤后的神经炎症阶段有价值的生物标志物对预后的研究进展进行综述。
Traumatic head injury is one of the leading causes of death or disability worldwide. Neuroinflam-mation from traumatic brain injury is a response to injury to brain or spinal cord cells. Neuroin-flammation is a complex phenomenon involving neuroimmune cells and glial cells (such as astro-cytes and microglia) within the brain that are activated and respond to damage by producing and releasing cytokines and inflammatory mediators. These cytokines, along with white blood cells at the site of brain injury, promote a coordinated response to injury. This article reviews the research progress of valuable biomarkers for prognosis in the neuroinflammatory stage after traumatic head injury.
[1] | Mollayeva, T., Mollayeva, S. and Colantonio, A. (2018) Traumatic Brain Injury: Sex, Gender and Intersecting Vulnera-bilities. Nature Reviews Neurology, 14, 711-722. https://doi.org/10.1038/s41582-018-0091-y |
[2] | Bossers, S.M., Loer, S.A., Bloemers, F.W., et al. (2020) Association between Prehospital Tranexamic Acid Administration and Out-comes of Severe Traumatic Brain Injury. JAMA Neurology, 78, 338-345.
https://doi.org/10.1001/jamaneurol.2020.4596 |
[3] | Jiang, J.-Y., Gao, G.-Y., Feng, J.-F., et al. (2019) Traumatic Brain Injury in China. The Lancet Neurology, 18, 286-295.
https://doi.org/10.1016/S1474-4422(18)30469-1 |
[4] | National Center for Health Statistics: Mortality Data on CDC WONDER. Centers for Disease Control and Prevention.
https://wonder.cdc.gov/mcd.html |
[5] | Bell, J.M., Breiding, M.J. and DePadilla, L. (2017) CDC’s Efforts to Im-prove Traumatic Brain Injury Surveillance. Journal of Safety Research, 62, 253-256. https://doi.org/10.1016/j.jsr.2017.04.002 |
[6] | Pearn, M.L., Niesman, I.R., Egawa, J., et al. (2017) Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. Cellular and Molecular Neurobiology, 37, 571-585.
https://doi.org/10.1007/s10571-016-0400-1 |
[7] | Eapen, B. and Cifu, D. (2018) Rehabilitation after Traumatic Brain Injury. Elsevier, St. Louis. |
[8] | Cuccurullo, S.J. (2010) Traumatic Brain Injury. In: Cuccurullo, S.J., Ed., Physical Med-icine and Rehabilitation Board Review, 2nd Edition, Demos Medical Publishing, New York, 49-50, 51-53, 90-91. |
[9] | Dixon, K.J. (2017) Pathophysiology of Traumatic Brain Injury. Physical Medicine and Rehabilitation Clin-ics of North America, 28, 215-225. https://doi.org/10.1016/j.pmr.2016.12.001 |
[10] | Chodobski, A., Zink, B.J. and Szmydynger-Chodobska, J. (2011) Blood-Brain Barrier Pathophysiology in Traumatic Brain Injury. Translational Stroke Research, 2, 492-516. https://doi.org/10.1007/s12975-011-0125-x |
[11] | Yarlagadda, A., Alfson, E. and Clayton, A.H. (2009) The Blood Brain Barrier and the Role of Cytokines in Neuropsychiatry. Psychiatry (Edgmont), 6, 18-22. |
[12] | Wong, A.D., Ye, M., Levy, A.F., et al. (2013) The Blood-Brain Barrier: An Engineering Perspective. Frontiers in Neuroengineering, 6, Article 7. https://doi.org/10.3389/fneng.2013.00007 |
[13] | Gayen, M., Bhomia, M., Balakathiresan, N. and Knollmann-Ritschel, B. (2020) Exosomal MicroRNAs Released by Activated Astrocytes as Potential Neuroinflammatory Biomarkers. International Journal of Molecular Sciences, 21, Article No. 2312. https://doi.org/10.3390/ijms21072312 |
[14] | Devoto, C., Arcurio, L., Fetta, J., Ley, M., Rodney, T., Kanefsky, R. and Gill, J. (2017) Inflammation Relates to Chronic Behavioral and Neurological Symptoms in Military Personnel with Traumatic Brain Injuries. Cell Transplantation, 26, 1169-1177. https://doi.org/10.1177/0963689717714098 |
[15] | Chiaretti, A., Antonelli, A., Mastrangelo, A., Pezzotti, P., Torto-rolo, L., Tosi, F. and Genovese, O. (2008) Interleukin-6 and Nerve Growth Factor Upregulation Correlates with Im-proved Outcome in Children with Severe Traumatic Brain Injury. Journal of Neurotrauma, 25, 225-234. https://doi.org/10.1089/neu.2007.0405 |
[16] | Hergenroeder, G.W., Moore, A.N., McCoy Jr., J.P., Samsel, L., Ward 3rd, N.H., Clifton, G.L. and Dash, P.K. (2010) Serum IL-6: A Candidate Biomarker for Intracranial Pressure Elevation Following Isolated Traumatic Brain Injury. Journal of Neuroinflammation, 7, Article No. 19. https://doi.org/10.1186/1742-2094-7-19 |
[17] | Mazzeo, A.T., Filippini, C., Rosato, R., Fanelli, V., Assenzio, B., Piper, I., Howells, T., Mastromauro, I., Berardino, M., Ducati, A. and Mascia, L. (2016) Multivariate Projection Method to Investigate Inflammation Associated with Secondary Insults and Outcome after Human Traumatic Brain Injury: A Pilot Study. Journal of Neuroinflammation, 13, Article No. 157. https://doi.org/10.1186/s12974-016-0624-5 |
[18] | Thompson, H.J., Martha, S.R., Wang, J. and Becker, K.J. (2020) Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 35, 324-331.
https://doi.org/10.1097/HTR.0000000000000606 |
[19] | Stein, D.M., Lindell, A.L., Murdock, K.R., Kufera, J.A., Menaker, J., Bochicchio, G.V., Aarabi, B. and Scalea, T.M. (2012) Use of Serum Biomarkers to Predict Cerebral Hy-poxia after Severe Traumatic Brain Injury. Journal of Neurotrauma, 29, 1140-1149. https://doi.org/10.1089/neu.2011.2149 |
[20] | Shetty, T., Cogsil, T., Dalal, A., Kim, E., Halvorsen, K., Cummings, K. and Nguyen, J.T. (2019) High-Sensitivity C-Reactive Protein: Retrospective Study of Potential Blood Biomarker of In-flammation in Acute Mild Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 34, E28-E36. https://doi.org/10.1097/HTR.0000000000000450 |
[21] | Irrera, N., Russo, M., Pallio, G., et al. (2020) The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury. International Journal of Molecular Sciences, 21, Article No. 6204. https://doi.org/10.3390/ijms21176204 |
[22] | Wallisch, J.S., Simon, D.W., Bay?r, H., Bell, M.J., Kochanek, P.M. and Clark, R.S.B. (2020) Cerebrospinal Fluid NLRP3 Is Increased after Severe Traumatic Brain Injury in Infants and Children. Neurocritical Care, 27, 44-50.
https://doi.org/10.1007/s12028-017-0378-7 |
[23] | Mishra, S.K., Kumar, B.S., Khushu, S., Singh, A.K. and Gangenahalli, G. (2020) Early Monitoring and Quantitative Evaluation of Macrophage Infiltration after Experimental Traumatic Brain Injury: A Magnetic Resonance Imaging and Flow Cytometric Analysis. Molecular and Cellular Neuro-science, 78, 25-34.
https://doi.org/10.1016/j.mcn.2016.11.008 |
[24] | Carabias, C.S., Gomez, P.A., Panero, I., Eiriz, C., Casta?o-León, A.M., Egea, J. and Lagares, A. (2020) Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procal-citonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry. World Neurosurgery, 134, e120-e143. https://doi.org/10.1016/j.wneu.2019.09.143 |
[25] | Di Battista, A.P., Buonora, J.E., Rhind, S.G., Hutchison, M.G., Baker, A.J., Rizoli, S.B., Diaz-Arrastia, R. and Mueller, G.P. (2015) Blood Biomarkers in Moderate-to-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome. Frontiers in Neurology, 6, Article 110. https://doi.org/10.3389/fneur.2015.00110 |
[26] | Gill, J., Latour, L., Diaz-Arrastia, R., Motamedi, V., Turtzo, C., Shahim, P., Mondello, S., DeVoto, C., Veras, E., Hanlon, D., Song, L. and Jeromin, A. (2018) Glial Fibrillary Acidic Protein Elevations Relate to Neuroimaging Abnormalities after Mild TBI. Neurology, 91, e1385-e1389. https://doi.org/10.1212/WNL.0000000000006321 |
[27] | Neri, M., Frati, A., Turillazzi, E., Cantatore, S., Cipolloni, L., Di Paolo, M., Frati, P., La Russa, R., Maiese, A., Scopetti, M., Santurro, A., Sessa, F., Zamparese, R. and Fineschi, V. (2018) Immunohistochemical Evaluation of Aquaporin-4 and Its Correlation with CD68, IBA-1, HIF-1α, GFAP, and CD15 Expressions in Fatal Traumatic Brain Injury. International Journal of Molecular Sciences, 19, Article No. 3544. https://doi.org/10.3390/ijms19113544 |
[28] | Bishop, P., Rocca, D. and Henley, J.M. (2016) Ubiquitin C-Terminal Hydrolase L1 (UCH-L1): Structure, Distribution and Roles in Brain Function and Dysfunction. Biochemical Journal, 473, 2453-2462.
https://doi.org/10.1042/BCJ20160082 |
[29] | Huibregtse, M.E., Bazarian, J.J., Shultz, S.R. and Kawata, K. (2021) The Biological Significance and Clinical Utility of Emerging Blood Biomarkers for Traumatic Brain Injury. Neuroscience & Biobehavioral Reviews, 130, 433-447.
https://doi.org/10.1016/j.neubiorev.2021.08.029 |
[30] | Paudel, Y.N., Angelopoulou, E., Piperi, C., Othman, I. and Shaikh, M.F. (2020) HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences, 21, Article No. 4609. https://doi.org/10.3390/ijms21134609 |
[31] | Chirico, V., Lacquaniti, A., Salpietro, V., Munafò, C., Calabrò, M.P., Buemi, M., Arrigo, T. and Salpietro, C. (2014) High-Mobility Group Box 1 (HMGB1) in Childhood: From Bench to Bedside. European Journal of Pediatrics, 173, 1123-1136. https://doi.org/10.1007/s00431-014-2327-1 |
[32] | Bohnert, S., Seiffert, A., Trella, S., Bohnert, M., Distel, L., Ondruschka, B. and Monoranu, C.-M. (2020) TMEM119 as a Specific Marker of Microglia Reaction in Traumatic Brain Injury in Postmortem Examination. International Journal of Legal Medicine, 134, 2167-2176. https://doi.org/10.1007/s00414-020-02384-z |
[33] | Lorente, L. (2015) New Prognostic Biomarkers in Patients with Traumatic Brain Injury. Archives of Trauma Research, 4, e30165. https://doi.org/10.5812/atr.30165 |
[34] | Lorente, L., Martín, M.M., Pérez-Cejas, A., González-Rivero, A.F., Argueso, M., Ramos, L., Solé-Violán, J., Cáceres, J.J., Ji-ménez, A. and García-Marín, V. (2019) Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury. World Neurosurgery, 132, e613-e617.
https://doi.org/10.1016/j.wneu.2019.08.064 |
[35] | Sedger, L.M. and McDermott, M.F. (2014) TNF and TNF-Receptors: From Mediators of Cell Death and Inflammation to Therapeutic Giants—Past, Present and Future. Cyto-kine & Growth Factor Reviews, 25, 453-472.
https://doi.org/10.1016/j.cytogfr.2014.07.016 |
[36] | Vijapur, S.M., Vaughan, L.E., Awan, N., DiSanto, D., McKernan, G.P. and Wagner, A.K. (2021) Treelet Transform Analysis to Identify Clusters of Systemic Inflammatory Variance in a Population with Moderate-to-Severe Traumatic Brain Injury. Brain, Behavior, and Immunity, 95, 45-60. https://doi.org/10.1016/j.bbi.2021.01.026 |